Viruses and sudden infant death.

Paediatr Respir Rev

Academic Department of Paediatrics, North Staffordshire Hospital, Stoke on Trent ST4 6QG, Staffordshire, UK.

Published: September 2003

Viral respiratory infections are the most likely trigger for sudden infant death syndrome (SIDS). SIDS cases commonly have evidence of respiratory tract inflammation, a preceding history of symptoms of minor illness and occur in winter peaks coinciding with respiratory viral epidemics. Respiratory infections are a common cause for infants presenting with sudden events, involving apnoea and hypoxaemia and there are physiological mechanisms by which infants may develop sudden and severe, potentially life-threatening hypoxaemia. The rate of SIDS has fallen in the last 15 years. This is probably more to do with the reasons for the fall in deaths from respiratory causes rather than changes in sleeping position. Further falls in SIDS death rates may occur with reductions in cigarette smoking, encouragement of breastfeeding and minimising the potential for young infants to acquire respiratory infections. Early identification and recognition of life-threatening features of infections may further minimise the risks of sudden death.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1526-0542(03)00050-2DOI Listing

Publication Analysis

Top Keywords

respiratory infections
12
sudden infant
8
infant death
8
respiratory
6
viruses sudden
4
death
4
death viral
4
viral respiratory
4
infections
4
infections trigger
4

Similar Publications

During the omicron wave of the COVID-19 pandemic and with SARS-CoV-2 vaccines becoming available, seroprevalence rates rose in children and adolescents. This study investigated the impact of both SARS-CoV-2 infections and vaccinations on the incidence of acute and prolonged symptoms in real-world conditions during the transition from the pandemic to the endemic phase. Participants from a pediatric population based seroprevalence study (CorKID study) were followed up at least two and for almost four years by survey of health status features and symptoms suggestive of post-COVID syndrome (PCS).

View Article and Find Full Text PDF

The COVID-19 pandemic may have impacted disabilities among people living with HIV; however, data on the association between COVID-19 pandemic-related healthcare disruptions and disabilities among people living with HIV is limited. We aimed to evaluate the association between COVID-19-affected HIV care behaviors and disability domains among people living with HIV in Belize. A cross-sectional study was conducted at the Western Regional Hospital and Southern Regional Hospital between August and October 2021 among people living with HIV in Belize aged ≥ 21 years and on antiretroviral therapy.

View Article and Find Full Text PDF

A woman in her 50s presented with redness, eye pain, watering and photophobia of the left eye starting 1 week after she tested positive for COVID-19. She was diagnosed with left eye episcleritis and started on topical steroids. As the steroids were being gradually tapered, she developed a recurrence.

View Article and Find Full Text PDF

Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy.

Nanomedicine (Lond)

January 2025

Clinical Laboratory Science Section, Institute of Medical Science Technology, Universiti Kuala Lumpur, Kajang, Selangor, Malaysia.

Phytochemicals are typically natural bioactive compounds or metabolites produced by plants. Phytochemical-loaded nanocarrier systems, designed to overcome bioavailability limitations and enhance therapeutic effects, have garnered significant attention in recent years. The coronavirus disease 2019 (COVID-19) pandemic has intensified interest in the therapeutic application of phytochemicals to combat viral infections.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!